CCS founder and president Tommy Cooper wrote “Lasers: The Next Generation of Fetal Monitoring” for the January 2016 edition of Medical Design Briefs. The article discusses the cerebral oxygen monitoring device CCS developed for Noninvasix, which is able to make non-invasive measurements of cerebral blood parameters.  This real-time data lets hospital staff identify adverse conditions immediately.  Quick actions can prevent brain damage and other serious conditions, and this device enables those actions.

This is the second time the project has been published in a technical journal article.  We are very happy it has been getting exposure and we would like to congratulate our client on their pioneering work in this field.

Visit our contact page and let us help you make your ground-breaking device idea a reality!